

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NADH metabolic process (GO:0006734) | 4.62046506 |
| 2 | protein localization to endosome (GO:0036010) | 4.60409619 |
| 3 | tricarboxylic acid cycle (GO:0006099) | 4.27288564 |
| 4 | succinate metabolic process (GO:0006105) | 4.15059948 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 4.08607278 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.08607278 |
| 7 | oxaloacetate metabolic process (GO:0006107) | 4.01527478 |
| 8 | lysine metabolic process (GO:0006553) | 3.94665490 |
| 9 | lysine catabolic process (GO:0006554) | 3.94665490 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.83814562 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 3.83814562 |
| 12 | aspartate family amino acid catabolic process (GO:0009068) | 3.81241105 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.79126581 |
| 14 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.72387672 |
| 15 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.68548834 |
| 16 | barbed-end actin filament capping (GO:0051016) | 3.48388511 |
| 17 | chaperone-mediated protein transport (GO:0072321) | 3.34243219 |
| 18 | negative regulation of cell size (GO:0045792) | 3.28824117 |
| 19 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.28670753 |
| 20 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.28670753 |
| 21 | synaptic vesicle exocytosis (GO:0016079) | 3.28448708 |
| 22 | peroxisome fission (GO:0016559) | 3.28158725 |
| 23 | coenzyme catabolic process (GO:0009109) | 3.27786066 |
| 24 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.24876084 |
| 25 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.23643676 |
| 26 | glutamate secretion (GO:0014047) | 3.21036049 |
| 27 | positive regulation of mitochondrial fission (GO:0090141) | 3.18894946 |
| 28 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.14748447 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.12542356 |
| 30 | piRNA metabolic process (GO:0034587) | 3.11475832 |
| 31 | cellular ketone body metabolic process (GO:0046950) | 3.10453579 |
| 32 | regulation of defense response to virus by virus (GO:0050690) | 3.09733269 |
| 33 | multicellular organism reproduction (GO:0032504) | 3.04717788 |
| 34 | mannose metabolic process (GO:0006013) | 3.03559957 |
| 35 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.03140003 |
| 36 | pinocytosis (GO:0006907) | 3.01398895 |
| 37 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.00514534 |
| 38 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.00371587 |
| 39 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.00346167 |
| 40 | protein retention in ER lumen (GO:0006621) | 2.96176601 |
| 41 | proline biosynthetic process (GO:0006561) | 2.95300981 |
| 42 | binding of sperm to zona pellucida (GO:0007339) | 2.95132275 |
| 43 | protein deneddylation (GO:0000338) | 2.93320914 |
| 44 | aromatic amino acid family catabolic process (GO:0009074) | 2.93188758 |
| 45 | pentose-phosphate shunt (GO:0006098) | 2.91825790 |
| 46 | neurotransmitter secretion (GO:0007269) | 2.89091710 |
| 47 | focal adhesion assembly (GO:0048041) | 2.88376401 |
| 48 | cell-substrate adherens junction assembly (GO:0007045) | 2.88376401 |
| 49 | gluconeogenesis (GO:0006094) | 2.86765907 |
| 50 | Golgi transport vesicle coating (GO:0048200) | 2.85873446 |
| 51 | COPI coating of Golgi vesicle (GO:0048205) | 2.85873446 |
| 52 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.84834937 |
| 53 | NIK/NF-kappaB signaling (GO:0038061) | 2.84126058 |
| 54 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.83717064 |
| 55 | dicarboxylic acid catabolic process (GO:0043649) | 2.83603592 |
| 56 | cullin deneddylation (GO:0010388) | 2.82479384 |
| 57 | adherens junction assembly (GO:0034333) | 2.82422464 |
| 58 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.81838668 |
| 59 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.81307878 |
| 60 | regulation of synaptic vesicle transport (GO:1902803) | 2.79183171 |
| 61 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.78130938 |
| 62 | basement membrane organization (GO:0071711) | 2.77556382 |
| 63 | bile acid biosynthetic process (GO:0006699) | 2.75777918 |
| 64 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.75666313 |
| 65 | hexose biosynthetic process (GO:0019319) | 2.74565336 |
| 66 | activation of Rac GTPase activity (GO:0032863) | 2.73702176 |
| 67 | alpha-amino acid catabolic process (GO:1901606) | 2.73405105 |
| 68 | branched-chain amino acid catabolic process (GO:0009083) | 2.72488719 |
| 69 | lactate metabolic process (GO:0006089) | 2.71852794 |
| 70 | glycosphingolipid catabolic process (GO:0046479) | 2.71006042 |
| 71 | transferrin transport (GO:0033572) | 2.69962108 |
| 72 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.69178234 |
| 73 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.68003241 |
| 74 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.67877211 |
| 75 | response to laminar fluid shear stress (GO:0034616) | 2.67334959 |
| 76 | positive regulation of nuclease activity (GO:0032075) | 2.65776177 |
| 77 | sperm-egg recognition (GO:0035036) | 2.64876860 |
| 78 | protein maturation by protein folding (GO:0022417) | 2.64614409 |
| 79 | skin morphogenesis (GO:0043589) | 2.64300079 |
| 80 | ketone body metabolic process (GO:1902224) | 2.62285563 |
| 81 | stress fiber assembly (GO:0043149) | 2.62077319 |
| 82 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.60908617 |
| 83 | cellular amino acid catabolic process (GO:0009063) | 2.58606329 |
| 84 | maternal placenta development (GO:0001893) | 2.58562064 |
| 85 | trivalent inorganic cation transport (GO:0072512) | 2.57610616 |
| 86 | ferric iron transport (GO:0015682) | 2.57610616 |
| 87 | urea metabolic process (GO:0019627) | 2.57201017 |
| 88 | urea cycle (GO:0000050) | 2.57201017 |
| 89 | regulation of coenzyme metabolic process (GO:0051196) | 2.56803437 |
| 90 | regulation of cofactor metabolic process (GO:0051193) | 2.56803437 |
| 91 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.56300440 |
| 92 | 2-oxoglutarate metabolic process (GO:0006103) | 2.55842748 |
| 93 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.55692935 |
| 94 | vesicle coating (GO:0006901) | 2.55031319 |
| 95 | NAD metabolic process (GO:0019674) | 2.54967514 |
| 96 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.54084239 |
| 97 | cofactor catabolic process (GO:0051187) | 2.53796839 |
| 98 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.53728661 |
| 99 | reproduction (GO:0000003) | 2.53200717 |
| 100 | glucose catabolic process (GO:0006007) | 2.53155985 |
| 101 | acyl-CoA biosynthetic process (GO:0071616) | 2.53033491 |
| 102 | thioester biosynthetic process (GO:0035384) | 2.53033491 |
| 103 | fructose metabolic process (GO:0006000) | 2.52649827 |
| 104 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.52542752 |
| 105 | tyrosine metabolic process (GO:0006570) | 2.52318269 |
| 106 | regulation of oxidative phosphorylation (GO:0002082) | 2.52249837 |
| 107 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.51041487 |
| 108 | response to insecticide (GO:0017085) | 2.50222450 |
| 109 | embryonic process involved in female pregnancy (GO:0060136) | 2.49850693 |
| 110 | germinal center formation (GO:0002467) | 2.49712164 |
| 111 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.48141316 |
| 112 | tricarboxylic acid metabolic process (GO:0072350) | 2.47903808 |
| 113 | cysteine metabolic process (GO:0006534) | 2.47726698 |
| 114 | NADPH regeneration (GO:0006740) | 2.47532898 |
| 115 | fatty acid elongation (GO:0030497) | 2.47277117 |
| 116 | glutamate metabolic process (GO:0006536) | 2.47132462 |
| 117 | monosaccharide biosynthetic process (GO:0046364) | 2.46134199 |
| 118 | amino sugar catabolic process (GO:0046348) | 2.45098763 |
| 119 | amino acid salvage (GO:0043102) | 2.44586276 |
| 120 | L-methionine salvage (GO:0071267) | 2.44586276 |
| 121 | L-methionine biosynthetic process (GO:0071265) | 2.44586276 |
| 122 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.44526358 |
| 123 | apoptotic process involved in morphogenesis (GO:0060561) | 2.43526756 |
| 124 | aromatic amino acid family metabolic process (GO:0009072) | 2.43118903 |
| 125 | glucose 6-phosphate metabolic process (GO:0051156) | 2.43065124 |
| 126 | ER-nucleus signaling pathway (GO:0006984) | 2.41629097 |
| 127 | cell-substrate junction assembly (GO:0007044) | 2.40943470 |
| 128 | regulation of nuclease activity (GO:0032069) | 2.40719904 |
| 129 | response to manganese ion (GO:0010042) | 2.40378181 |
| 130 | membrane protein ectodomain proteolysis (GO:0006509) | 2.39926705 |
| 131 | synaptic vesicle endocytosis (GO:0048488) | 2.39881171 |
| 132 | regulation of cholesterol homeostasis (GO:2000188) | 2.39862082 |
| 133 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.39570679 |
| 134 | glycolipid catabolic process (GO:0019377) | 2.39475664 |
| 135 | sulfur amino acid catabolic process (GO:0000098) | 2.39049374 |
| 136 | acetyl-CoA metabolic process (GO:0006084) | 2.38932437 |
| 137 | cell-cell recognition (GO:0009988) | 2.38384614 |
| 138 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.38250174 |
| 139 | modulation by symbiont of host cellular process (GO:0044068) | 2.38078574 |
| 140 | amino-acid betaine metabolic process (GO:0006577) | 2.37773323 |
| 141 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.36800007 |
| 142 | synaptic vesicle maturation (GO:0016188) | 2.36433279 |
| 143 | heme transport (GO:0015886) | 2.35989088 |
| 144 | cellular response to unfolded protein (GO:0034620) | 2.35844667 |
| 145 | regulation of acrosome reaction (GO:0060046) | 2.35667735 |
| 146 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.35340872 |
| 147 | negative regulation of viral release from host cell (GO:1902187) | 2.34714037 |
| 148 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.34632173 |
| 149 | glyoxylate metabolic process (GO:0046487) | 2.34489170 |
| 150 | alpha-linolenic acid metabolic process (GO:0036109) | 2.33910286 |
| 151 | nitrogen cycle metabolic process (GO:0071941) | 2.33884838 |
| 152 | response to water (GO:0009415) | 2.33872776 |
| 153 | regulation of neurotransmitter levels (GO:0001505) | 2.33782175 |
| 154 | neurotransmitter transport (GO:0006836) | 2.33710843 |
| 155 | regulation of early endosome to late endosome transport (GO:2000641) | 2.33710070 |
| 156 | proline transport (GO:0015824) | 2.32844736 |
| 157 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.31883209 |
| 158 | aspartate family amino acid metabolic process (GO:0009066) | 2.31826787 |
| 159 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.31809525 |
| 160 | regulation of gamma-delta T cell activation (GO:0046643) | 2.31603038 |
| 161 | negative regulation of fibrinolysis (GO:0051918) | 2.31351854 |
| 162 | regulation of leukocyte degranulation (GO:0043300) | 2.31123744 |
| 163 | positive regulation of protein dephosphorylation (GO:0035307) | 2.31032072 |
| 164 | regulation of mitochondrial fission (GO:0090140) | 2.30249912 |
| 165 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.30142366 |
| 166 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.30033058 |
| 167 | gamma-aminobutyric acid transport (GO:0015812) | 2.30020028 |
| 168 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.29292197 |
| 169 | bile acid metabolic process (GO:0008206) | 2.28918116 |
| 170 | actin filament depolymerization (GO:0030042) | 2.28821498 |
| 171 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.28695836 |
| 172 | negative regulation of cell killing (GO:0031342) | 2.28695836 |
| 173 | acyl-CoA metabolic process (GO:0006637) | 2.28600258 |
| 174 | thioester metabolic process (GO:0035383) | 2.28600258 |
| 175 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.27223681 |
| 176 | regulation of histone H3-K27 methylation (GO:0061085) | 2.26028805 |
| 177 | COPII vesicle coating (GO:0048208) | 2.25423616 |
| 178 | regulation of necrotic cell death (GO:0010939) | 2.25346989 |
| 179 | regulation of superoxide anion generation (GO:0032928) | 2.25279465 |
| 180 | desmosome organization (GO:0002934) | 2.24624471 |
| 181 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.24325753 |
| 182 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.20866960 |
| 183 | response to peptidoglycan (GO:0032494) | 2.20370284 |
| 184 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.19111625 |
| 185 | embryo implantation (GO:0007566) | 2.18796295 |
| 186 | nuclear envelope reassembly (GO:0031468) | 2.16667605 |
| 187 | mitotic nuclear envelope reassembly (GO:0007084) | 2.16667605 |
| 188 | regulation of extracellular matrix disassembly (GO:0010715) | 2.15098200 |
| 189 | negative regulation of necroptotic process (GO:0060546) | 2.14917680 |
| 190 | positive regulation of extracellular matrix organization (GO:1903055) | 2.14347228 |
| 191 | cellular response to interleukin-4 (GO:0071353) | 2.14345199 |
| 192 | amyloid precursor protein catabolic process (GO:0042987) | 2.13942628 |
| 193 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.13851671 |
| 194 | thymic T cell selection (GO:0045061) | 2.13773017 |
| 195 | cellular response to topologically incorrect protein (GO:0035967) | 2.13630939 |
| 196 | tolerance induction (GO:0002507) | 2.12951168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.62834561 |
| 2 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.00140360 |
| 3 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.92306030 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.90451329 |
| 5 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.87061703 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.73331576 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.57034413 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.56718552 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.50898798 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.50147127 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.49393358 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.49060205 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.46495373 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.43167697 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.41776254 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.37598358 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.35544192 |
| 18 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.35381990 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.32081024 |
| 20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.30264552 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.28913834 |
| 22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.28183908 |
| 23 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.26259630 |
| 24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.25012473 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.15845559 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.14595464 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.14134756 |
| 28 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.11435743 |
| 29 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.10235822 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.08219391 |
| 31 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.05618665 |
| 32 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.03816246 |
| 33 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02982763 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.95734652 |
| 35 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.95205531 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.91635580 |
| 37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.87533099 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.83355958 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.80084654 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.79502104 |
| 41 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.77595922 |
| 42 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.75938887 |
| 43 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.74956622 |
| 44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.71157898 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.69941840 |
| 46 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.67605710 |
| 47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.66781357 |
| 48 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.63881485 |
| 49 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.62243601 |
| 50 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60326079 |
| 51 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.56119581 |
| 52 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.55941189 |
| 53 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.53950824 |
| 54 | MAF_26560356_Chip-Seq_TH1_Human | 1.50550179 |
| 55 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49866337 |
| 56 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.49019889 |
| 57 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48968044 |
| 58 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.47542684 |
| 59 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46950499 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.46462597 |
| 61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.44775817 |
| 62 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43696770 |
| 63 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.43291753 |
| 64 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.42991556 |
| 65 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.42157372 |
| 66 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.40338298 |
| 67 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.40201782 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40080293 |
| 69 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.39222414 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.38008511 |
| 71 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.36995493 |
| 72 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35739725 |
| 73 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.35343098 |
| 74 | UTX_26944678_Chip-Seq_JUKART_Human | 1.34632692 |
| 75 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.34119652 |
| 76 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33898453 |
| 77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31983477 |
| 78 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.30977468 |
| 79 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30665852 |
| 80 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.30458296 |
| 81 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30409295 |
| 82 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.29436047 |
| 83 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.29150539 |
| 84 | MAF_26560356_Chip-Seq_TH2_Human | 1.28766295 |
| 85 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27741473 |
| 86 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.27570920 |
| 87 | ATF3_27146783_Chip-Seq_COLON_Human | 1.27270787 |
| 88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.27143440 |
| 89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27123052 |
| 90 | P68_20966046_ChIP-Seq_HELA_Human | 1.27114610 |
| 91 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26917577 |
| 92 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26643842 |
| 93 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.26283604 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25261845 |
| 95 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.25140265 |
| 96 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.24332830 |
| 97 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.23849940 |
| 98 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.23511463 |
| 99 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.23140248 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22454533 |
| 101 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.20890032 |
| 102 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19406823 |
| 103 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18321771 |
| 104 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.17892625 |
| 105 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.17624229 |
| 106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17238982 |
| 107 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17231757 |
| 108 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.16670879 |
| 109 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.16070931 |
| 110 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.15352651 |
| 111 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.15315090 |
| 112 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14925576 |
| 113 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.14909829 |
| 114 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14442933 |
| 115 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14319956 |
| 116 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13904868 |
| 117 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11445708 |
| 118 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10228920 |
| 119 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.10100450 |
| 120 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09726778 |
| 121 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09681026 |
| 122 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.08576113 |
| 123 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.08294279 |
| 124 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.07775056 |
| 125 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07724451 |
| 126 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.07433846 |
| 127 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05938646 |
| 128 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.05847755 |
| 129 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05726233 |
| 130 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05365807 |
| 131 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.04263061 |
| 132 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.04164066 |
| 133 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.03986983 |
| 134 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.03913644 |
| 135 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03913024 |
| 136 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03648073 |
| 137 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03501450 |
| 138 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02451455 |
| 139 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.02435936 |
| 140 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02251314 |
| 141 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.02147358 |
| 142 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01642920 |
| 143 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.01571592 |
| 144 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01563976 |
| 145 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.01124073 |
| 146 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98251536 |
| 147 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.98052050 |
| 148 | NCOR_22424771_ChIP-Seq_293T_Human | 0.96370930 |
| 149 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93711724 |
| 150 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93682781 |
| 151 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.93078315 |
| 152 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.91053661 |
| 153 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90749876 |
| 154 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.89579404 |
| 155 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.88306073 |
| 156 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.85845842 |
| 157 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.84632485 |
| 158 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.84044477 |
| 159 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.83423118 |
| 160 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.82694682 |
| 161 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.82123317 |
| 162 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.81691151 |
| 163 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.81589886 |
| 164 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.81191985 |
| 165 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81134722 |
| 166 | ERA_21632823_ChIP-Seq_H3396_Human | 0.80793601 |
| 167 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.80593735 |
| 168 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.79523492 |
| 169 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78765534 |
| 170 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.78091677 |
| 171 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.77302659 |
| 172 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.76670737 |
| 173 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.76298729 |
| 174 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.75012666 |
| 175 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.74350566 |
| 176 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.74119313 |
| 177 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.73863874 |
| 178 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.73690307 |
| 179 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.73604805 |
| 180 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.73604805 |
| 181 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.73355386 |
| 182 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.72544632 |
| 183 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.72449156 |
| 184 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72178159 |
| 185 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.71981087 |
| 186 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.71975461 |
| 187 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.71456900 |
| 188 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.70860875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.41186955 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.61770289 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.40189632 |
| 4 | MP0005365_abnormal_bile_salt | 3.27903711 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.21532571 |
| 6 | MP0005360_urolithiasis | 2.97234505 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 2.91483059 |
| 8 | MP0003172_abnormal_lysosome_physiology | 2.75744886 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.74187113 |
| 10 | MP0003880_abnormal_central_pattern | 2.72526509 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.69501533 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.62357018 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.54493404 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.39246337 |
| 15 | MP0003436_decreased_susceptibility_to | 2.35692520 |
| 16 | MP0002736_abnormal_nociception_after | 2.27711632 |
| 17 | MP0005083_abnormal_biliary_tract | 2.22663349 |
| 18 | MP0003646_muscle_fatigue | 2.14837305 |
| 19 | MP0002909_abnormal_adrenal_gland | 2.14707577 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 2.14612015 |
| 21 | MP0001968_abnormal_touch/_nociception | 2.12124603 |
| 22 | MP0003303_peritoneal_inflammation | 2.09132148 |
| 23 | MP0009046_muscle_twitch | 2.06335009 |
| 24 | MP0003566_abnormal_cell_adhesion | 2.05342663 |
| 25 | MP0003195_calcinosis | 2.02318139 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 2.02067436 |
| 27 | MP0003635_abnormal_synaptic_transmissio | 2.01895882 |
| 28 | MP0002064_seizures | 2.00879958 |
| 29 | MP0005646_abnormal_pituitary_gland | 1.96435237 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.92364643 |
| 31 | MP0002822_catalepsy | 1.91308786 |
| 32 | MP0006035_abnormal_mitochondrial_morpho | 1.90045794 |
| 33 | MP0009745_abnormal_behavioral_response | 1.89918250 |
| 34 | MP0001529_abnormal_vocalization | 1.88807519 |
| 35 | MP0001905_abnormal_dopamine_level | 1.86131886 |
| 36 | MP0003329_amyloid_beta_deposits | 1.83652996 |
| 37 | MP0004036_abnormal_muscle_relaxation | 1.81635691 |
| 38 | MP0000013_abnormal_adipose_tissue | 1.80536920 |
| 39 | MP0004270_analgesia | 1.78513136 |
| 40 | MP0006276_abnormal_autonomic_nervous | 1.75573809 |
| 41 | MP0002272_abnormal_nervous_system | 1.73533846 |
| 42 | MP0003453_abnormal_keratinocyte_physiol | 1.73219911 |
| 43 | MP0010329_abnormal_lipoprotein_level | 1.69061593 |
| 44 | MP0005332_abnormal_amino_acid | 1.65494301 |
| 45 | MP0001849_ear_inflammation | 1.65484909 |
| 46 | MP0004043_abnormal_pH_regulation | 1.64520542 |
| 47 | MP0008438_abnormal_cutaneous_collagen | 1.64493911 |
| 48 | MP0002796_impaired_skin_barrier | 1.64468502 |
| 49 | MP0000751_myopathy | 1.63902263 |
| 50 | MP0002063_abnormal_learning/memory/cond | 1.63597204 |
| 51 | MP0005410_abnormal_fertilization | 1.60674118 |
| 52 | MP0004185_abnormal_adipocyte_glucose | 1.59987543 |
| 53 | MP0002734_abnormal_mechanical_nocicepti | 1.59323433 |
| 54 | MP0004947_skin_inflammation | 1.58624742 |
| 55 | MP0002572_abnormal_emotion/affect_behav | 1.58498489 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.53642150 |
| 57 | MP0003763_abnormal_thymus_physiology | 1.51158126 |
| 58 | MP0003075_altered_response_to | 1.50603281 |
| 59 | MP0009333_abnormal_splenocyte_physiolog | 1.49753139 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.47125176 |
| 61 | MP0001666_abnormal_nutrient_absorption | 1.46992983 |
| 62 | MP0000858_altered_metastatic_potential | 1.44628789 |
| 63 | MP0004142_abnormal_muscle_tone | 1.44558034 |
| 64 | MP0009840_abnormal_foam_cell | 1.44277735 |
| 65 | MP0004924_abnormal_behavior | 1.42306382 |
| 66 | MP0005386_behavior/neurological_phenoty | 1.42306382 |
| 67 | MP0004145_abnormal_muscle_electrophysio | 1.41440505 |
| 68 | MP0003879_abnormal_hair_cell | 1.40872445 |
| 69 | MP0002269_muscular_atrophy | 1.40496769 |
| 70 | MP0002735_abnormal_chemical_nociception | 1.38150643 |
| 71 | MP0001853_heart_inflammation | 1.38038650 |
| 72 | MP0008877_abnormal_DNA_methylation | 1.35508849 |
| 73 | MP0004510_myositis | 1.32981317 |
| 74 | MP0003718_maternal_effect | 1.32294469 |
| 75 | MP0000749_muscle_degeneration | 1.31870990 |
| 76 | MP0003091_abnormal_cell_migration | 1.31490861 |
| 77 | MP0001440_abnormal_grooming_behavior | 1.29411376 |
| 78 | MP0009278_abnormal_bone_marrow | 1.29058296 |
| 79 | MP0000604_amyloidosis | 1.28879335 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 1.27552917 |
| 81 | MP0001533_abnormal_skeleton_physiology | 1.27190078 |
| 82 | MP0004264_abnormal_extraembryonic_tissu | 1.26367280 |
| 83 | MP0000747_muscle_weakness | 1.26174148 |
| 84 | MP0009780_abnormal_chondrocyte_physiolo | 1.25792168 |
| 85 | MP0002419_abnormal_innate_immunity | 1.25515000 |
| 86 | MP0000750_abnormal_muscle_regeneration | 1.24838447 |
| 87 | MP0002067_abnormal_sensory_capabilities | 1.24562557 |
| 88 | MP0005000_abnormal_immune_tolerance | 1.22427316 |
| 89 | MP0000733_abnormal_muscle_development | 1.21724860 |
| 90 | MP0005025_abnormal_response_to | 1.21624084 |
| 91 | MP0002118_abnormal_lipid_homeostasis | 1.21597072 |
| 92 | MP0005257_abnormal_intraocular_pressure | 1.21518365 |
| 93 | MP0005330_cardiomyopathy | 1.19448396 |
| 94 | MP0004084_abnormal_cardiac_muscle | 1.19393687 |
| 95 | MP0002060_abnormal_skin_morphology | 1.19151491 |
| 96 | MP0001764_abnormal_homeostasis | 1.18253266 |
| 97 | MP0002148_abnormal_hypersensitivity_rea | 1.17912380 |
| 98 | MP0004087_abnormal_muscle_fiber | 1.16578243 |
| 99 | MP0002254_reproductive_system_inflammat | 1.16496806 |
| 100 | MP0000759_abnormal_skeletal_muscle | 1.16141779 |
| 101 | MP0008260_abnormal_autophagy | 1.16132814 |
| 102 | MP0005535_abnormal_body_temperature | 1.15109890 |
| 103 | MP0008872_abnormal_physiological_respon | 1.14182448 |
| 104 | MP0005501_abnormal_skin_physiology | 1.13129358 |
| 105 | MP0002078_abnormal_glucose_homeostasis | 1.12360535 |
| 106 | MP0005451_abnormal_body_composition | 1.11853758 |
| 107 | MP0009697_abnormal_copulation | 1.11665424 |
| 108 | MP0004130_abnormal_muscle_cell | 1.09273999 |
| 109 | MP0004858_abnormal_nervous_system | 1.09197995 |
| 110 | MP0004233_abnormal_muscle_weight | 1.08397208 |
| 111 | MP0005464_abnormal_platelet_physiology | 1.08283129 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 1.07034827 |
| 113 | MP0003279_aneurysm | 1.06512179 |
| 114 | MP0004811_abnormal_neuron_physiology | 1.03432036 |
| 115 | MP0005165_increased_susceptibility_to | 1.03182271 |
| 116 | MP0001835_abnormal_antigen_presentation | 1.02881274 |
| 117 | MP0000003_abnormal_adipose_tissue | 1.02869947 |
| 118 | MP0002733_abnormal_thermal_nociception | 1.01780930 |
| 119 | MP0002452_abnormal_antigen_presenting | 1.01349915 |
| 120 | MP0002396_abnormal_hematopoietic_system | 1.01092102 |
| 121 | MP0002229_neurodegeneration | 1.00996621 |
| 122 | MP0004215_abnormal_myocardial_fiber | 1.00703442 |
| 123 | MP0001970_abnormal_pain_threshold | 1.00665741 |
| 124 | MP0010155_abnormal_intestine_physiology | 1.00356923 |
| 125 | MP0002723_abnormal_immune_serum | 0.98170275 |
| 126 | MP0001790_abnormal_immune_system | 0.98132959 |
| 127 | MP0005387_immune_system_phenotype | 0.98132959 |
| 128 | MP0010352_gastrointestinal_tract_polyps | 0.98089256 |
| 129 | MP0005023_abnormal_wound_healing | 0.97174392 |
| 130 | MP0002653_abnormal_ependyma_morphology | 0.95813826 |
| 131 | MP0010386_abnormal_urinary_bladder | 0.95753683 |
| 132 | MP0001216_abnormal_epidermal_layer | 0.95519358 |
| 133 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95033979 |
| 134 | MP0001501_abnormal_sleep_pattern | 0.94537806 |
| 135 | MP0003868_abnormal_feces_composition | 0.94321811 |
| 136 | MP0003828_pulmonary_edema | 0.94087540 |
| 137 | MP0006138_congestive_heart_failure | 0.93511768 |
| 138 | MP0001929_abnormal_gametogenesis | 0.93255352 |
| 139 | MP0000685_abnormal_immune_system | 0.93020718 |
| 140 | MP0001819_abnormal_immune_cell | 0.92472349 |
| 141 | MP0005266_abnormal_metabolism | 0.92294304 |
| 142 | MP0005621_abnormal_cell_physiology | 0.92050529 |
| 143 | MP0005670_abnormal_white_adipose | 0.91945826 |
| 144 | MP0005375_adipose_tissue_phenotype | 0.91799659 |
| 145 | MP0005666_abnormal_adipose_tissue | 0.91511240 |
| 146 | MP0005166_decreased_susceptibility_to | 0.91440764 |
| 147 | MP0002420_abnormal_adaptive_immunity | 0.91378809 |
| 148 | MP0003633_abnormal_nervous_system | 0.90469005 |
| 149 | MP0002066_abnormal_motor_capabilities/c | 0.90412287 |
| 150 | MP0002998_abnormal_bone_remodeling | 0.90340360 |
| 151 | MP0003183_abnormal_peptide_metabolism | 0.89214137 |
| 152 | MP0003122_maternal_imprinting | 0.87614090 |
| 153 | MP0001800_abnormal_humoral_immune | 0.87237513 |
| 154 | MP0000609_abnormal_liver_physiology | 0.86991529 |
| 155 | MP0003448_altered_tumor_morphology | 0.86801668 |
| 156 | MP0009785_altered_susceptibility_to | 0.86570199 |
| 157 | MP0005636_abnormal_mineral_homeostasis | 0.86134473 |
| 158 | MP0008469_abnormal_protein_level | 0.84129042 |
| 159 | MP0008569_lethality_at_weaning | 0.83764318 |
| 160 | MP0006082_CNS_inflammation | 0.83679202 |
| 161 | MP0001881_abnormal_mammary_gland | 0.83635977 |
| 162 | MP0003698_abnormal_male_reproductive | 0.83342860 |
| 163 | MP0002332_abnormal_exercise_endurance | 0.81053005 |
| 164 | MP0003631_nervous_system_phenotype | 0.80857583 |
| 165 | MP0004147_increased_porphyrin_level | 0.79959397 |
| 166 | MP0010630_abnormal_cardiac_muscle | 0.79557757 |
| 167 | MP0002398_abnormal_bone_marrow | 0.79463239 |
| 168 | MP0002089_abnormal_postnatal_growth/wei | 0.78442794 |
| 169 | MP0002896_abnormal_bone_mineralization | 0.78194839 |
| 170 | MP0001845_abnormal_inflammatory_respons | 0.77991711 |
| 171 | MP0001661_extended_life_span | 0.77319410 |
| 172 | MP0002166_altered_tumor_susceptibility | 0.76840429 |
| 173 | MP0001756_abnormal_urination | 0.76500693 |
| 174 | MP0003953_abnormal_hormone_level | 0.74995216 |
| 175 | MP0001243_abnormal_dermal_layer | 0.74751332 |
| 176 | MP0001730_embryonic_growth_arrest | 0.74470970 |
| 177 | MP0004085_abnormal_heartbeat | 0.74423897 |
| 178 | MP0001958_emphysema | 0.73736938 |
| 179 | MP0009931_abnormal_skin_appearance | 0.73724852 |
| 180 | MP0000343_altered_response_to | 0.73365380 |
| 181 | MP0008874_decreased_physiological_sensi | 0.73332002 |
| 182 | MP0001486_abnormal_startle_reflex | 0.73327948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pheochromocytoma (HP:0002666) | 3.76843936 |
| 2 | Abnormality of glycolysis (HP:0004366) | 3.71517419 |
| 3 | Increased serum pyruvate (HP:0003542) | 3.71517419 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.52556206 |
| 5 | Acute encephalopathy (HP:0006846) | 3.40610491 |
| 6 | Neuroendocrine neoplasm (HP:0100634) | 3.33611678 |
| 7 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.32727627 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 3.27617383 |
| 9 | Vertebral compression fractures (HP:0002953) | 3.16266882 |
| 10 | Hepatocellular necrosis (HP:0001404) | 3.16065745 |
| 11 | Increased connective tissue (HP:0009025) | 3.11824548 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.11400106 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.11400106 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.11400106 |
| 15 | Distal lower limb muscle weakness (HP:0009053) | 3.09939318 |
| 16 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.08314557 |
| 17 | Gout (HP:0001997) | 3.06109438 |
| 18 | Hypobetalipoproteinemia (HP:0003563) | 3.05373489 |
| 19 | Atonic seizures (HP:0010819) | 3.04871001 |
| 20 | Progressive macrocephaly (HP:0004481) | 3.04525629 |
| 21 | Focal motor seizures (HP:0011153) | 3.02939404 |
| 22 | Deep venous thrombosis (HP:0002625) | 3.02382646 |
| 23 | Cholecystitis (HP:0001082) | 3.00391344 |
| 24 | Abnormal gallbladder physiology (HP:0012438) | 3.00391344 |
| 25 | Hepatic necrosis (HP:0002605) | 2.98452036 |
| 26 | Cerebral edema (HP:0002181) | 2.93468590 |
| 27 | Dysostosis multiplex (HP:0000943) | 2.90697478 |
| 28 | Hyperventilation (HP:0002883) | 2.90320590 |
| 29 | Ketosis (HP:0001946) | 2.86976551 |
| 30 | Mitochondrial inheritance (HP:0001427) | 2.84737097 |
| 31 | Hyperglycinemia (HP:0002154) | 2.84277822 |
| 32 | Increased CSF lactate (HP:0002490) | 2.78163219 |
| 33 | Hyperacusis (HP:0010780) | 2.66940354 |
| 34 | Premature rupture of membranes (HP:0001788) | 2.65271221 |
| 35 | Intrahepatic cholestasis (HP:0001406) | 2.65264679 |
| 36 | Eczematoid dermatitis (HP:0000976) | 2.65229028 |
| 37 | Achilles tendon contracture (HP:0001771) | 2.63880220 |
| 38 | Distal lower limb amyotrophy (HP:0008944) | 2.60648658 |
| 39 | Ketoacidosis (HP:0001993) | 2.50061509 |
| 40 | Progressive muscle weakness (HP:0003323) | 2.49642860 |
| 41 | Xanthomatosis (HP:0000991) | 2.48391970 |
| 42 | Oligomenorrhea (HP:0000876) | 2.47879421 |
| 43 | Hypokinesia (HP:0002375) | 2.45025371 |
| 44 | Poor suck (HP:0002033) | 2.44750724 |
| 45 | Myokymia (HP:0002411) | 2.44468621 |
| 46 | Lactic acidosis (HP:0003128) | 2.44372215 |
| 47 | Increased cerebral lipofuscin (HP:0011813) | 2.44047207 |
| 48 | Epileptic encephalopathy (HP:0200134) | 2.43378497 |
| 49 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.42319304 |
| 50 | Epileptiform EEG discharges (HP:0011182) | 2.41842175 |
| 51 | Asymmetric septal hypertrophy (HP:0001670) | 2.40725890 |
| 52 | Cholelithiasis (HP:0001081) | 2.38949899 |
| 53 | Loss of speech (HP:0002371) | 2.36705730 |
| 54 | Hyperammonemia (HP:0001987) | 2.36640847 |
| 55 | Abnormality of the Achilles tendon (HP:0005109) | 2.35922894 |
| 56 | Mucopolysacchariduria (HP:0008155) | 2.35470284 |
| 57 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.35470284 |
| 58 | J-shaped sella turcica (HP:0002680) | 2.35468982 |
| 59 | Abnormal gallbladder morphology (HP:0012437) | 2.35287873 |
| 60 | EEG with generalized epileptiform discharges (HP:0011198) | 2.35259801 |
| 61 | Myopathic facies (HP:0002058) | 2.33560681 |
| 62 | Axonal loss (HP:0003447) | 2.32757403 |
| 63 | Methylmalonic aciduria (HP:0012120) | 2.31157744 |
| 64 | Exercise-induced myalgia (HP:0003738) | 2.30728617 |
| 65 | Lethargy (HP:0001254) | 2.30377484 |
| 66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.29839550 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.29839550 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.29839550 |
| 69 | Abnormality of the lower motor neuron (HP:0002366) | 2.29567659 |
| 70 | CNS demyelination (HP:0007305) | 2.27559595 |
| 71 | Myoglobinuria (HP:0002913) | 2.26774783 |
| 72 | Hypsarrhythmia (HP:0002521) | 2.24600883 |
| 73 | Hyperlipoproteinemia (HP:0010980) | 2.22982423 |
| 74 | Brushfield spots (HP:0001088) | 2.22949814 |
| 75 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.18610912 |
| 76 | Abnormality of glycine metabolism (HP:0010895) | 2.18610912 |
| 77 | Respiratory failure (HP:0002878) | 2.18293007 |
| 78 | Conjunctival hamartoma (HP:0100780) | 2.18022726 |
| 79 | Difficulty climbing stairs (HP:0003551) | 2.16830242 |
| 80 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.15896793 |
| 81 | Spastic gait (HP:0002064) | 2.15733214 |
| 82 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.15084697 |
| 83 | Exercise-induced muscle cramps (HP:0003710) | 2.15023062 |
| 84 | Muscle fiber inclusion bodies (HP:0100299) | 2.14838691 |
| 85 | Abnormality of macrophages (HP:0004311) | 2.14249708 |
| 86 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.13105269 |
| 87 | Thin bony cortex (HP:0002753) | 2.12764269 |
| 88 | Type 1 muscle fiber predominance (HP:0003803) | 2.11315302 |
| 89 | Cerebral aneurysm (HP:0004944) | 2.11238107 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 2.11031652 |
| 91 | Neoplasm of the adrenal gland (HP:0100631) | 2.10615860 |
| 92 | Cervical subluxation (HP:0003308) | 2.10031137 |
| 93 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09452286 |
| 94 | Osteolytic defects of the hand bones (HP:0009699) | 2.09452286 |
| 95 | Emotional lability (HP:0000712) | 2.08854229 |
| 96 | Cerebral inclusion bodies (HP:0100314) | 2.08777432 |
| 97 | Protrusio acetabuli (HP:0003179) | 2.08401055 |
| 98 | Nemaline bodies (HP:0003798) | 2.08211240 |
| 99 | Distal upper limb amyotrophy (HP:0007149) | 2.06666233 |
| 100 | Upper limb amyotrophy (HP:0009129) | 2.06666233 |
| 101 | Supranuclear gaze palsy (HP:0000605) | 2.06239507 |
| 102 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.05195769 |
| 103 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.05120425 |
| 104 | Leukodystrophy (HP:0002415) | 2.04907916 |
| 105 | Hypolipoproteinemia (HP:0010981) | 2.04165099 |
| 106 | Rhabdomyolysis (HP:0003201) | 2.04077912 |
| 107 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.03620264 |
| 108 | Neuronal loss in central nervous system (HP:0002529) | 2.02966695 |
| 109 | Dicarboxylic aciduria (HP:0003215) | 2.02723422 |
| 110 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.02723422 |
| 111 | Broad face (HP:0000283) | 2.02253125 |
| 112 | Cellulitis (HP:0100658) | 2.02133428 |
| 113 | Hemorrhage of the eye (HP:0011885) | 2.02096685 |
| 114 | Hypoglycemic coma (HP:0001325) | 2.01873316 |
| 115 | Failure to thrive in infancy (HP:0001531) | 2.01726086 |
| 116 | Absence seizures (HP:0002121) | 2.01224496 |
| 117 | Abnormality of methionine metabolism (HP:0010901) | 2.00970634 |
| 118 | Hyperglycinuria (HP:0003108) | 2.00952422 |
| 119 | Delusions (HP:0000746) | 2.00839845 |
| 120 | Infertility (HP:0000789) | 2.00087507 |
| 121 | Interstitial pulmonary disease (HP:0006530) | 1.99918006 |
| 122 | Cerebral hypomyelination (HP:0006808) | 1.98821275 |
| 123 | Generalized tonic-clonic seizures (HP:0002069) | 1.98176850 |
| 124 | Fatigue (HP:0012378) | 1.97416525 |
| 125 | Short nail (HP:0001799) | 1.97017431 |
| 126 | Hyporeflexia of lower limbs (HP:0002600) | 1.95929455 |
| 127 | Ragged-red muscle fibers (HP:0003200) | 1.95333765 |
| 128 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.95267839 |
| 129 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.95080953 |
| 130 | Increased variability in muscle fiber diameter (HP:0003557) | 1.94879677 |
| 131 | Abnormality of pain sensation (HP:0010832) | 1.93650523 |
| 132 | Impaired pain sensation (HP:0007328) | 1.93650523 |
| 133 | Increased serum lactate (HP:0002151) | 1.93643039 |
| 134 | Hyperthyroidism (HP:0000836) | 1.92827357 |
| 135 | Slow saccadic eye movements (HP:0000514) | 1.92365800 |
| 136 | Abnormality of serum amino acid levels (HP:0003112) | 1.91517400 |
| 137 | Retinal atrophy (HP:0001105) | 1.88590000 |
| 138 | Nuclear cataract (HP:0100018) | 1.88544169 |
| 139 | Neurofibrillary tangles (HP:0002185) | 1.88227231 |
| 140 | Delayed gross motor development (HP:0002194) | 1.87587178 |
| 141 | Obstructive sleep apnea (HP:0002870) | 1.87557164 |
| 142 | Anxiety (HP:0000739) | 1.87443854 |
| 143 | Abnormality of the gallbladder (HP:0005264) | 1.85617532 |
| 144 | Progressive external ophthalmoplegia (HP:0000590) | 1.85546206 |
| 145 | Focal seizures (HP:0007359) | 1.85369003 |
| 146 | Hamartoma of the eye (HP:0010568) | 1.84256168 |
| 147 | Metabolic acidosis (HP:0001942) | 1.84172186 |
| 148 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.83957037 |
| 149 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.83924234 |
| 150 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.83670328 |
| 151 | Flat acetabular roof (HP:0003180) | 1.83060611 |
| 152 | Insomnia (HP:0100785) | 1.83041235 |
| 153 | Visual hallucinations (HP:0002367) | 1.82113050 |
| 154 | Agitation (HP:0000713) | 1.81830078 |
| 155 | Generalized amyotrophy (HP:0003700) | 1.81111811 |
| 156 | Increased IgE level (HP:0003212) | 1.80291361 |
| 157 | Muscular hypotonia of the trunk (HP:0008936) | 1.79840774 |
| 158 | Dialeptic seizures (HP:0011146) | 1.79235269 |
| 159 | Clonus (HP:0002169) | 1.79146904 |
| 160 | Autoamputation (HP:0001218) | 1.78369862 |
| 161 | Increased serum ferritin (HP:0003281) | 1.77491366 |
| 162 | Insidious onset (HP:0003587) | 1.77205307 |
| 163 | Termporal pattern (HP:0011008) | 1.77205307 |
| 164 | Spastic paraparesis (HP:0002313) | 1.77024825 |
| 165 | Sensorimotor neuropathy (HP:0007141) | 1.76977611 |
| 166 | Lower limb amyotrophy (HP:0007210) | 1.76711835 |
| 167 | Increased muscle lipid content (HP:0009058) | 1.76670045 |
| 168 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.76351238 |
| 169 | Abnormality of the thoracic spine (HP:0100711) | 1.74711002 |
| 170 | Trismus (HP:0000211) | 1.73916663 |
| 171 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.73879309 |
| 172 | Progressive neurologic deterioration (HP:0002344) | 1.71324271 |
| 173 | Polygenic inheritance (HP:0010982) | 1.71315287 |
| 174 | Bone pain (HP:0002653) | 1.71135037 |
| 175 | Spinal rigidity (HP:0003306) | 1.69683814 |
| 176 | Natal tooth (HP:0000695) | 1.69489448 |
| 177 | Myocardial infarction (HP:0001658) | 1.69449529 |
| 178 | EMG: myopathic abnormalities (HP:0003458) | 1.69361263 |
| 179 | Apathy (HP:0000741) | 1.68726000 |
| 180 | Sparse lateral eyebrow (HP:0005338) | 1.67814851 |
| 181 | Neck muscle weakness (HP:0000467) | 1.65812065 |
| 182 | Back pain (HP:0003418) | 1.65430389 |
| 183 | Gastrointestinal stroma tumor (HP:0100723) | 1.65372367 |
| 184 | Foot dorsiflexor weakness (HP:0009027) | 1.63532441 |
| 185 | Hepatosplenomegaly (HP:0001433) | 1.63358386 |
| 186 | Dilatation of the ascending aorta (HP:0005111) | 1.61509556 |
| 187 | Rigidity (HP:0002063) | 1.61095718 |
| 188 | Rough bone trabeculation (HP:0100670) | 1.61058028 |
| 189 | Abnormality of oral frenula (HP:0000190) | 1.60979809 |
| 190 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.60702062 |
| 191 | Bulbar palsy (HP:0001283) | 1.59536720 |
| 192 | Diminished motivation (HP:0000745) | 1.59026680 |
| 193 | Recurrent abscess formation (HP:0002722) | 1.58830662 |
| 194 | Aneurysm (HP:0002617) | 1.58681864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.93222662 |
| 2 | INSRR | 3.60909174 |
| 3 | ERN1 | 3.53961622 |
| 4 | CASK | 3.52732389 |
| 5 | FRK | 3.52578372 |
| 6 | PDK3 | 3.51139196 |
| 7 | PDK4 | 3.51139196 |
| 8 | SMG1 | 2.83983810 |
| 9 | BCKDK | 2.76928387 |
| 10 | TSSK6 | 2.70893728 |
| 11 | MAP2K7 | 2.63104370 |
| 12 | MAP3K4 | 2.57638868 |
| 13 | NTRK3 | 2.52436673 |
| 14 | PRKD3 | 2.49486913 |
| 15 | TESK2 | 2.42000786 |
| 16 | AKT3 | 2.31688319 |
| 17 | IRAK3 | 2.31524382 |
| 18 | TTN | 2.17322241 |
| 19 | MAP3K13 | 2.15373704 |
| 20 | PDK2 | 2.13511972 |
| 21 | NME2 | 2.13142956 |
| 22 | RIPK1 | 2.10208103 |
| 23 | MAP3K9 | 2.09190397 |
| 24 | ICK | 2.06828097 |
| 25 | TESK1 | 1.99547202 |
| 26 | BRAF | 1.99341244 |
| 27 | CDK19 | 1.99022333 |
| 28 | EPHA2 | 1.88976293 |
| 29 | CCNB1 | 1.85947582 |
| 30 | MAP2K3 | 1.84609610 |
| 31 | MAP2K4 | 1.74416083 |
| 32 | MAP3K3 | 1.68755661 |
| 33 | FGFR2 | 1.64289371 |
| 34 | MAP3K12 | 1.63077545 |
| 35 | PKN2 | 1.61438060 |
| 36 | NME1 | 1.58716212 |
| 37 | MAPKAPK5 | 1.56996228 |
| 38 | CDK12 | 1.55808282 |
| 39 | TBK1 | 1.53504931 |
| 40 | DAPK2 | 1.51649604 |
| 41 | MAP3K14 | 1.49537737 |
| 42 | OXSR1 | 1.45033686 |
| 43 | PINK1 | 1.42891505 |
| 44 | TAOK2 | 1.41860493 |
| 45 | PAK4 | 1.40252930 |
| 46 | DAPK1 | 1.36237305 |
| 47 | OBSCN | 1.35157239 |
| 48 | BUB1 | 1.32068565 |
| 49 | MAP3K11 | 1.27649882 |
| 50 | NEK1 | 1.27179603 |
| 51 | ARAF | 1.26277225 |
| 52 | MST1R | 1.25120969 |
| 53 | MINK1 | 1.18245227 |
| 54 | MAPK11 | 1.18016455 |
| 55 | EIF2AK1 | 1.17341557 |
| 56 | PNCK | 1.15050301 |
| 57 | KSR2 | 1.13931894 |
| 58 | PIM2 | 1.12301535 |
| 59 | PTK2B | 1.08017005 |
| 60 | PHKG2 | 1.07868007 |
| 61 | PHKG1 | 1.07868007 |
| 62 | PLK2 | 1.06742255 |
| 63 | PRKCG | 1.04141970 |
| 64 | PDGFRA | 1.03509737 |
| 65 | TYK2 | 1.03389376 |
| 66 | TAOK1 | 0.99854399 |
| 67 | EPHA4 | 0.97087433 |
| 68 | PRKD2 | 0.96162584 |
| 69 | MAPKAPK3 | 0.96005618 |
| 70 | ZAP70 | 0.94804617 |
| 71 | WNK4 | 0.93101437 |
| 72 | MAP4K1 | 0.93032611 |
| 73 | RIPK4 | 0.92883950 |
| 74 | SGK494 | 0.92279594 |
| 75 | SGK223 | 0.92279594 |
| 76 | ERBB4 | 0.88533767 |
| 77 | MTOR | 0.83585204 |
| 78 | CDK5 | 0.83250348 |
| 79 | PTK6 | 0.82634957 |
| 80 | MAP2K1 | 0.81999076 |
| 81 | CAMK2A | 0.81147375 |
| 82 | MAP3K8 | 0.80746048 |
| 83 | NEK6 | 0.80685908 |
| 84 | PLK3 | 0.79256237 |
| 85 | TAOK3 | 0.76063849 |
| 86 | LIMK1 | 0.75870148 |
| 87 | CDC42BPA | 0.75777694 |
| 88 | MARK1 | 0.75545936 |
| 89 | SIK1 | 0.74762392 |
| 90 | STK38 | 0.74183158 |
| 91 | MYLK | 0.73296080 |
| 92 | JAK3 | 0.72745190 |
| 93 | EEF2K | 0.72718438 |
| 94 | PBK | 0.72176259 |
| 95 | BLK | 0.71850212 |
| 96 | PRPF4B | 0.70808913 |
| 97 | PAK6 | 0.70166410 |
| 98 | PTK2 | 0.70064620 |
| 99 | LMTK2 | 0.69796843 |
| 100 | RPS6KB2 | 0.69263947 |
| 101 | STK39 | 0.67899866 |
| 102 | JAK1 | 0.66665358 |
| 103 | CSK | 0.65074516 |
| 104 | NTRK1 | 0.64988241 |
| 105 | STK10 | 0.64739012 |
| 106 | DAPK3 | 0.64272871 |
| 107 | CAMK2B | 0.64231573 |
| 108 | MAPK13 | 0.63174944 |
| 109 | LRRK2 | 0.62827084 |
| 110 | MOS | 0.62326892 |
| 111 | RAF1 | 0.61837913 |
| 112 | PRKCZ | 0.61738076 |
| 113 | CAMK2G | 0.61720234 |
| 114 | NTRK2 | 0.61714130 |
| 115 | MARK2 | 0.60235526 |
| 116 | KSR1 | 0.59941346 |
| 117 | PRKCH | 0.59795758 |
| 118 | EPHB1 | 0.58175949 |
| 119 | TNK2 | 0.58046626 |
| 120 | BMX | 0.57856229 |
| 121 | CAMKK1 | 0.57298696 |
| 122 | PDK1 | 0.54033849 |
| 123 | SGK2 | 0.52818088 |
| 124 | PDPK1 | 0.52767229 |
| 125 | SCYL2 | 0.52583720 |
| 126 | STK16 | 0.51985611 |
| 127 | HIPK2 | 0.51295979 |
| 128 | MAP2K2 | 0.51244908 |
| 129 | RET | 0.51227379 |
| 130 | PKN1 | 0.50857599 |
| 131 | CDK6 | 0.49930937 |
| 132 | IRAK4 | 0.49408471 |
| 133 | PRKG2 | 0.48553252 |
| 134 | CAMK2D | 0.47392653 |
| 135 | PRKCI | 0.45049827 |
| 136 | MAPKAPK2 | 0.44913566 |
| 137 | IKBKB | 0.44103864 |
| 138 | RPS6KA2 | 0.43367587 |
| 139 | MAP3K2 | 0.43165971 |
| 140 | GRK6 | 0.43061183 |
| 141 | SIK3 | 0.42784661 |
| 142 | IRAK2 | 0.42755274 |
| 143 | LATS2 | 0.42671361 |
| 144 | MAPK12 | 0.42220214 |
| 145 | DMPK | 0.42060675 |
| 146 | JAK2 | 0.41872834 |
| 147 | MAP3K1 | 0.41472417 |
| 148 | IKBKE | 0.41376501 |
| 149 | CDK14 | 0.40810330 |
| 150 | CDK18 | 0.40468676 |
| 151 | AKT2 | 0.40421000 |
| 152 | BCR | 0.39754915 |
| 153 | PAK3 | 0.39640225 |
| 154 | CSNK1G3 | 0.38607489 |
| 155 | CDK8 | 0.38379786 |
| 156 | ALK | 0.37337084 |
| 157 | CDK7 | 0.37145500 |
| 158 | PRKACB | 0.36839810 |
| 159 | STK11 | 0.36386408 |
| 160 | CDK15 | 0.35584621 |
| 161 | PRKAA1 | 0.35500615 |
| 162 | GRK5 | 0.35118073 |
| 163 | CDK4 | 0.34976668 |
| 164 | CSNK1G2 | 0.34945002 |
| 165 | EIF2AK3 | 0.33478992 |
| 166 | RPS6KA3 | 0.33002395 |
| 167 | HCK | 0.32937984 |
| 168 | FGFR4 | 0.31957026 |
| 169 | PRKCE | 0.31887018 |
| 170 | SGK3 | 0.31451547 |
| 171 | DDR2 | 0.30869344 |
| 172 | FER | 0.30577712 |
| 173 | CSF1R | 0.30360782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.53061451 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.49929662 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.47397231 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.92730349 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.72919099 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67152793 |
| 7 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.55208646 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.54643708 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.51771888 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.48982893 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.23005098 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.12421719 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.11976467 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.08027403 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.07223923 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.05696970 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.00634104 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.98650827 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.96635538 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.94723659 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.87979295 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.87462857 |
| 23 | Carbon metabolism_Homo sapiens_hsa01200 | 1.82137666 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.81654581 |
| 25 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.77734028 |
| 26 | Parkinsons disease_Homo sapiens_hsa05012 | 1.75434939 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.71892999 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.70385641 |
| 29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.66149008 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64285713 |
| 31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.57863566 |
| 32 | Prion diseases_Homo sapiens_hsa05020 | 1.56990140 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53256633 |
| 34 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.50236475 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.48829627 |
| 36 | Bladder cancer_Homo sapiens_hsa05219 | 1.47665628 |
| 37 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.46166822 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44498974 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.42921980 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.40763019 |
| 41 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40218625 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.40020711 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.39367988 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.37372757 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.34195709 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.32468464 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.25531703 |
| 48 | Proteasome_Homo sapiens_hsa03050 | 1.23233444 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21277629 |
| 50 | Nicotine addiction_Homo sapiens_hsa05033 | 1.20897852 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.20313001 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 1.17519673 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.16498210 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.16491196 |
| 55 | Huntingtons disease_Homo sapiens_hsa05016 | 1.14273470 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 1.14154149 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13879560 |
| 58 | Thyroid cancer_Homo sapiens_hsa05216 | 1.12327382 |
| 59 | Alzheimers disease_Homo sapiens_hsa05010 | 1.09549472 |
| 60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.07555265 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.06076042 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.05861947 |
| 63 | Insulin secretion_Homo sapiens_hsa04911 | 1.04174583 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03853913 |
| 65 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.00114346 |
| 66 | Tuberculosis_Homo sapiens_hsa05152 | 0.99672002 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98737968 |
| 68 | Hepatitis B_Homo sapiens_hsa05161 | 0.98490314 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.97886331 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96942032 |
| 71 | Influenza A_Homo sapiens_hsa05164 | 0.96484456 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.96152921 |
| 73 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.95981635 |
| 74 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.94940843 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94787021 |
| 76 | Protein export_Homo sapiens_hsa03060 | 0.94498359 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.94375644 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93465425 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92904754 |
| 80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92551933 |
| 81 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.92422293 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.91944912 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91889686 |
| 84 | GABAergic synapse_Homo sapiens_hsa04727 | 0.91238444 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.90353501 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.89366073 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89291224 |
| 88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.88259613 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.87468334 |
| 90 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.87299333 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86097160 |
| 92 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.86083402 |
| 93 | Salmonella infection_Homo sapiens_hsa05132 | 0.85578816 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.85167916 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83125658 |
| 96 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.83122794 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.81603302 |
| 98 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81355635 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.81288539 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.81144122 |
| 101 | Measles_Homo sapiens_hsa05162 | 0.79646284 |
| 102 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79366137 |
| 103 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79332734 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78514201 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.78251478 |
| 106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.77423506 |
| 107 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.77380242 |
| 108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77216409 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.76995325 |
| 110 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76234898 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74905254 |
| 112 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.74697203 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.74589841 |
| 114 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74164615 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73852057 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73694679 |
| 117 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.73650695 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.73262453 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.73131635 |
| 120 | Pertussis_Homo sapiens_hsa05133 | 0.72983804 |
| 121 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72702434 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72115112 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.71107243 |
| 124 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70029502 |
| 125 | Legionellosis_Homo sapiens_hsa05134 | 0.69559667 |
| 126 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69111873 |
| 127 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68469380 |
| 128 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68354880 |
| 129 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68077273 |
| 130 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66818933 |
| 131 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66739443 |
| 132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66658907 |
| 133 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.65430395 |
| 134 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65006080 |
| 135 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64722914 |
| 136 | Long-term potentiation_Homo sapiens_hsa04720 | 0.63079036 |
| 137 | Metabolic pathways_Homo sapiens_hsa01100 | 0.62962330 |
| 138 | Focal adhesion_Homo sapiens_hsa04510 | 0.62593990 |
| 139 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.62221446 |
| 140 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62148987 |
| 141 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.61110667 |
| 142 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60935387 |
| 143 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60476211 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59576128 |
| 145 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.58977891 |
| 146 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58587273 |
| 147 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.58482676 |
| 148 | Prostate cancer_Homo sapiens_hsa05215 | 0.57578317 |
| 149 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57034539 |
| 150 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.56070155 |
| 151 | Circadian entrainment_Homo sapiens_hsa04713 | 0.52781667 |
| 152 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52456905 |
| 153 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51190773 |
| 154 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50528985 |
| 155 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.49929261 |
| 156 | Olfactory transduction_Homo sapiens_hsa04740 | 0.49283507 |
| 157 | Phagosome_Homo sapiens_hsa04145 | 0.48011404 |
| 158 | Lysine degradation_Homo sapiens_hsa00310 | 0.47864014 |
| 159 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47202928 |
| 160 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.46105850 |
| 161 | Morphine addiction_Homo sapiens_hsa05032 | 0.45018137 |
| 162 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44584733 |
| 163 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44322904 |
| 164 | Cocaine addiction_Homo sapiens_hsa05030 | 0.44288331 |
| 165 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43116798 |
| 166 | Long-term depression_Homo sapiens_hsa04730 | 0.39469680 |
| 167 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38299584 |
| 168 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.37598330 |
| 169 | ABC transporters_Homo sapiens_hsa02010 | 0.37147829 |
| 170 | Renin secretion_Homo sapiens_hsa04924 | 0.35080529 |
| 171 | Salivary secretion_Homo sapiens_hsa04970 | 0.34899629 |
| 172 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33752817 |
| 173 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33553776 |
| 174 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.33299831 |
| 175 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33027484 |
| 176 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32064283 |
| 177 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.31710887 |
| 178 | Taste transduction_Homo sapiens_hsa04742 | 0.31143297 |
| 179 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.29784168 |
| 180 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28265675 |
| 181 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.27265407 |

